BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6582845)

  • 1. Radical radiotherapy for carcinoma of the prostate: localized and extended field treatment.
    Nacey JN
    Aust N Z J Surg; 1983 Dec; 53(6):561-5. PubMed ID: 6582845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation therapy of inoperable localized prostate carcinoma: an assessment of tumor response and complications.
    Green N; Melbye RW; George FW; Morrow J
    J Urol; 1974 May; 111(5):662-4. PubMed ID: 4207372
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy.
    Mishra MV; Shirazi R; Barrett WL
    Clin Genitourin Cancer; 2007 Sep; 5(6):397-400. PubMed ID: 17956713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative external beam radiotherapy for prostate carcinoma: results in 231 patients treated in Lyon.
    Gerard JP; Xie C; Carrie C; Romestaing P; Pommier P; Mornex F; Clippe S; Sentenac I; Ginestet C
    Aust N Z J Surg; 1999 Oct; 69(10):707-11. PubMed ID: 10527346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An experience with dose-escalated conformal radiation therapy in hormone-radiotherapy for prostate cancer].
    Gumenetskaya YV; Mardynsky YS; Karyakin OB; Gulidov IA; Biryukov VA
    Vopr Onkol; 2015; 61(1):57-61. PubMed ID: 26016147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral pelvic lymphadenectomy, iridium 192 template, and external beam therapy for localized prostatic carcinoma: complications and results.
    Klein FA; Ali MM; Marks SE; Hackler RH
    South Med J; 1988 Jan; 81(1):27-31. PubMed ID: 3336796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pitfalls of treating anorectal conditions after radiotherapy for prostate cancer.
    Thornhill JA; Long RM; Neary P; O'Connor HJ; Ryan B; Fraser I
    Ir Med J; 2012 Mar; 105(3):91-3. PubMed ID: 22558821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late results of combined iodine-125 and external beam radiotherapy in carcinoma of prostate.
    Patel J; Worthen R; Abadir R; Weaver DJ; Weinstein S; Ross G
    Urology; 1990 Jul; 36(1):27-30. PubMed ID: 2368228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose radiotherapy for localized prostatic cancer. An analysis of treatment results and early complications.
    Kearsley JH
    Med J Aust; 1986 Jun; 144(12):624-8. PubMed ID: 3086680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate.
    Lawton CA; Yan Y; Lee WR; Gillin M; Firat S; Baikadi M; Crook J; Kuettel M; Morton G; Sandler H
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e795-801. PubMed ID: 22330999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer.
    Jo Y; Hiratsuka J; Fujii T; Takenaka A; Fujisawa M
    Urology; 2004 Sep; 64(3):556-60. PubMed ID: 15351592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications following external radiotherapy of prostate cancer. Case reports and overview of the literature].
    Schmiedt E; Schmeller N; Mayer P
    Urologe A; 1984 May; 23(3):149-52. PubMed ID: 6539989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation proctitis after prostate carcinoma therapy.
    Donaldson SS
    JAMA; 1994 Mar; 271(11):819-20. PubMed ID: 8114228
    [No Abstract]   [Full Text] [Related]  

  • 14. Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate.
    Mameghan H; Fisher R; Mameghan J; Brook S
    Aust N Z J Surg; 1994 Jun; 64(6):389-94. PubMed ID: 8010899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral sucralfate on the acute proctitis associated with prostate radiotherapy: a double-blind, randomized trial.
    Kneebone A; Mameghan H; Bolin T; Berry M; Turner S; Kearsley J; Graham P; Fisher R; Delaney G
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):628-35. PubMed ID: 11597802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate.
    Pilepich MV; Krall J; George FW; Asbell SO; Plenk HD; Johnson RJ; Stetz J; Zinninger M; Walz BJ
    Int J Radiat Oncol Biol Phys; 1984 Oct; 10(10):1861-7. PubMed ID: 6386761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer.
    Christiansen H; Saile B; Hermann RM; Rave-Fränk M; Hille A; Schmidberger H; Hess CF; Ramadori G
    J Cancer Res Clin Oncol; 2007 May; 133(5):297-304. PubMed ID: 17393200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radical external radiotherapy for prostatic carcinoma.
    Beiler DD; Wright DJ; Reddy GN
    Int J Radiat Oncol Biol Phys; 1981 Jul; 7(7):885-90. PubMed ID: 6796551
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary observations on the results of combined 125iodine seed implantation and external irradiation for carcinoma of the prostate.
    Ross G; Borkon WD; Landry LJ; Edwards FM; Weinstein SH; Abadir R
    J Urol; 1982 Apr; 127(4):699-701. PubMed ID: 7069833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.
    Dearnaley DP; Khoo VS; Norman AR; Meyer L; Nahum A; Tait D; Yarnold J; Horwich A
    Lancet; 1999 Jan; 353(9149):267-72. PubMed ID: 9929018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.